Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma.

Source:http://linkedlifedata.com/resource/pubmed/id/19660004

Download in:

View as

General Info

PMID
19660004